资讯

āshibio Doses First Patient in Phase 1b Trial of Andecaliximab in Patients with Spinal ...
BRISBANE, Calif., June 24, 2025--āshibio, a privately held, clinical-stage biotechnology company developing novel therapeutics for the treatment of severe bone and connective tissue disorders, today ...
How Blood Pressure medicines can deplete nutrients from the body (and what to do about it)
As we all know, calcium is essential for strong bones and teeth, muscle contractions, nerve signaling, and blood clotting.How ...